Community Outreach

Overview

Even though Novo Nordisk invests more in diabetes research than any
other company, we know that changing diabetes and delivering on our Triple Bottom Line cannot be achieved
through science alone.

That’s why we actively support our employees to translate our
principles into practice, while contributing annually to the most
impactful regional, national and global organizations. From partnering
with the American Diabetes Association and the National Hemophilia
Foundation, to offering innovative treatments, education, and testing
to underserved communities, to lending a hand in community service
projects focused on environmental change – our team thrives on finding
solutions where the need is greatest.

TakeAction!

Novo Nordisk’s TakeAction! Program encourages employees to engage in
voluntary activities during work hours in local communities here in
the U.S. and around the globe. Since its start in 2003, the
TakeAction! Program has led thousands of activities inspired by our
own employees.

Here are just a few of the broad range of initiatives carried out by TakeAction!:

Participating in events such as
Princeton ADA StepOut Walk and the Walk to Fight Diabetes

Leading the way as the top fundraising team at the Princeton
Tour de Cure

Raising hundreds of thousands of dollars for
Camp Challenge events and activities that serve children with
diabetes and hemophilia

Providing school and athletic
supplies along with diabetes testing and education in Tanzania,
Africa

Renovating schools like the Kissimmee/Highlands
Elementary School in Osceolo County, Alabama

Facilitating
ongoing mentorship programs with Trenton High School students who
have expressed an interest in law and justice careers

Building homes for those in need with Habitat for Humanity

Taking part in the Gulf clean-up activities after the Deepwater
Horizon oil spill

Delivering thousands of shoes to the
Haitian people via the Step Up for Haiti program

First comprehensive national
benchmark against which we can measure the public’s understanding of
diabetes, its economic impact, and gaps in diabetes measurement

CHANGING DIABETES® IN CHILDREN

Novo Nordisk works in
cooperation with local partners, governments and diabetes
associations in some of the world’s poorest countries to build
sustainable national capacity for diabetes treatment and create
clinics for children with type 1 diabetes

SUPPORTING POLICY TO BREAK THE CURVE OF THE DIABETES PANDEMIC

Novo Nordisk supports several
major pieces of legislation in the US Congress to address diabetes
care and treatment, including the Preventive Health Savings Act and
the Catalyst to Better Diabetes Care Act

Novo
Nordisk USA

Headquartered in Denmark, Novo Nordisk is a global healthcare
company with 95 years of innovation and leadership in diabetes care.
This heritage has given us experience and capabilities that also
enable us to help people defeat other serious chronic conditions: rare
bleeding disorders, growth hormone-related disorders, and obesity.

All personal information reported in relation
to a complaint or a side effect will be processed in accordance with
applicable data protection legislation. For avoidance of doubt, “data
protection legislation” means the law governing the Novo Nordisk
entity receiving the complaint or report, not the residence or
location of the individual data subject submitting the report or
complaint:

Your report is used solely for the scientific evaluation of
the medicine and product quality.

Side effects are filed in
our global safety database and the data is regularly analyzed for
overall patterns.

Novo Nordisk may share reported
complaints and side effects with health authorities as mandated by
law, regulation or as required by court order.

Novo Nordisk
will retain the data consistent with Novo Nordisk’s data retention
policies and as long as required by law.